New Drug Achieves Pancreatic Cancer Tumor Remission And Prevents Recurrence, Study Suggests
Sunday, April 19, 2009 - 17:07
in Health & Medicine
Pancreatic cancer remains one of the deadliest cancers, but researchers may have found a combination therapy to reduce cancer stem cells and stop pancreatic cancer growth. Treatment with gemcitabine and tigatuzumab resulted in the reduction of pancreatic cancer stem cells, caused tumor remission, and significantly increased time-to-tumor progression in 50 percent of treated cases from a median of 54 days to 103 days.
Read the whole article on Science Daily
More from Science Daily
Related
- New drug achieves pancreatic cancer tumor remission and prevents recurrenceSun, 19 Apr 2009, 15:29:49 EDT
- Is mirtazapine and fluoxetine helpful in treating pancreatic cancer?Wed, 24 Sep 2008, 10:44:03 EDT
- Radiation before surgery improves pancreatic cancer outcomesTue, 25 Nov 2008, 18:15:01 EST
- Possible origins of pancreatic cancer revealedMon, 2 Nov 2009, 12:39:41 EST
- A promising approach in the prevention and treatment of pancreatic cancerThu, 25 Sep 2008, 9:43:12 EDT